For research use only. Not for human or veterinary use. Not for diagnostic or therapeutic use.
Menu
Reconstitution calculator

Cited duration

NAD+ study duration

The study cited for NAD+ lasted 1 week. It is a study duration, not a recommended cycle, and no off period is stated. Population in the source: Adults with ischemic cardiomyopathy heart failure, single-center randomized placebo-controlled trial, intravenous.[1]

Human trial

Sam, MBA · Human-researched and AI-assisted with full editorial review.

About the source: Intravenous NAD+ daily for 7 days alongside guideline-directed therapy (7 days = 1 week). Study duration, not a recommended cycle.

Study duration

1 week[1] Human trial

Duration of the cited study. It describes the source and is not a recommended cycle; no off period is stated. Source

References

Numbered sources used on this page. Markers in the text link here.

  1. pubmed.ncbi.nlm.nih.gov Human trial